BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chang YT, Ling TC, Cheng YY, Sun CY, Wu JL, Tai CH, Wang JR, Sung JM. Comparison of Immunogenicity and Safety between a Single Dose and One Booster Trivalent Inactivated Influenza Vaccination in Patients with Chronic Kidney Disease: A 20-Week, Open-Label Trial. Vaccines (Basel) 2021;9:192. [PMID: 33669067 DOI: 10.3390/vaccines9030192] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Füessl L, Lau T, Lean I, Hasmann S, Riedl B, Arend FM, Sorodoc-otto J, Soreth-rieke D, Toepfer M, Rau S, Salihi-halimi H, Paal M, Beuthien W, Thaller N, Suttmann Y, von Gersdorff G, Regenauer R, von Bergwelt-baildon A, Teupser D, Bruegel M, Fischereder M, Schönermarck U. Diminished Short- and Long-Term Antibody Response after SARS-CoV-2 Vaccination in Hemodialysis Patients. Vaccines 2022;10:605. [DOI: 10.3390/vaccines10040605] [Reference Citation Analysis]
2 Paal M, Arend FM, Lau T, Hasmann S, Soreth-Rieke D, Sorodoc-Otto J, Beuthien W, Krappe J, Toepfer M, von Gersdorff G, Thaller N, Rau S, Northoff B, Teupser D, Bruegel M, Fischereder M, Schönermarck U. Antibody response to mRNA SARS-CoV-2 vaccines in haemodialysis patients. Clin Kidney J 2021;14:2234-8. [PMID: 34603700 DOI: 10.1093/ckj/sfab127] [Reference Citation Analysis]
3 Kann M, Benzing T. [Update 2021: COVID-19 from the perspective of nephrology]. Dtsch Med Wochenschr 2021;146:915-7. [PMID: 34256408 DOI: 10.1055/a-1449-5068] [Reference Citation Analysis]